People

  1. Lee
    Lee
  2. Bhatia
    Bhatia
  3. Sanchez
    Sanchez
  4. Luo
    Luo
  5. Gharzeddine
    Gharzeddine
  6. D'Angelo
    D'Angelo
  7. Papadopoulos
    Papadopoulos
  8. Younes
    Younes
  9. Sadinski
    Sadinski
  10. Lux
    Lux
  11. Feigin
    Feigin
  12. Lezcano Lopez
    Lezcano Lopez
  13. Borquez-Ojeda
    Borquez-Ojeda
  14. Klang
    Klang
  15. Warbet
    Warbet

Recent Works

  1. Patient-centered outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
    Meeting Abstract

    Bedel, D. J.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  2. Cost-effectiveness of a 24-month fixed duration of venetoclax in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia in the United States
    Meeting Abstract

    Huntington, S. F.; Strunz-McKendry, T.; Masaquel, A. S.; Shapouri, S.; Sail, K.; Durno, N.; Mato, A.
    Value in Health (2019)

    Fulltext@MSK | Save
  3. Quality adjusted time without symptoms of disease progression or toxicity (Q-TWIST) of nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) among untreated advanced renal cell carcinoma (ARCC) patients (patients) with intermediate or poor prognostic risk
    Meeting Abstract

    Shah, R.; Botteman, M.; Kwon, Y.; Gooden, K. M.; Cella, D.; Motzer, R.
    Value in Health (2019)

    Fulltext@MSK | Save